Literature DB >> 19318639

The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries.

Nadia Howlader1, Lynn A Ries, David G Stinchcomb, Brenda K Edwards.   

Abstract

Reduced cancer reporting by the US Department of Veterans Affairs (VA) hospitals in 2007 (for patients diagnosed through 2005) impacted the most recent US cancer surveillance data. To quantify the impact of the reduced VA reporting on cancer incidence and trends produced by the Surveillance, Epidemiology, and End Results Program, we estimated numbers of missing VA patients in 2005 by sex, age, race, selected cancer sites, and registry and calculated adjustment factors to correct for the 2005 incidence rates and trends. Based on our adjustment factors, we estimated that as a result of the underreporting, the overall cancer burden was underestimated by 1.6% for males and 0.05% for females. For males, the percentage of patients missing ranged from 2.5% for liver cancer to 0.4% for melanoma of the skin. For age-adjusted male overall cancer incidence rates, the adjustment factors were 1.015, 1.012, and 1.035 for all races, white males, and black males, respectively. Modest changes in long-term incidence trends were observed, particularly in black males.

Entities:  

Mesh:

Year:  2009        PMID: 19318639      PMCID: PMC2720708          DOI: 10.1093/jnci/djn517

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  4 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Unreported VA data may affect SEER research, cancer surveillance, and statistics gathering.

Authors:  Liz Savage
Journal:  J Natl Cancer Inst       Date:  2007-11-27       Impact factor: 13.506

3.  Accuracy of US cancer surveillance under threat.

Authors:  Bryant Furlow
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

4.  Impact of reporting delay and reporting error on cancer incidence rates and trends.

Authors:  Limin X Clegg; Eric J Feuer; Douglas N Midthune; Michael P Fay; Benjamin F Hankey
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

  4 in total
  35 in total

1.  Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.

Authors:  Leah L Zullig; George L Jackson; Raye Anne Dorn; Dawn T Provenzale; Rebecca McNeil; Catherine M Thomas; Michael J Kelley
Journal:  Mil Med       Date:  2012-06       Impact factor: 1.437

2.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

Authors:  Quinn T Ostrom; Haley Gittleman; Paul Farah; Annie Ondracek; Yanwen Chen; Yingli Wolinsky; Nancy E Stroup; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2013-11       Impact factor: 12.300

3.  Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?

Authors:  Elena Elimova; Hironori Shiozaki; Rebecca S Slack; Hsiang-Chun Chen; Roopma Wadhwa; Kazuki Sudo; Nikolaos Charalampakis; Adarsh Hiremath; Jeannelyn S Estrella; Aurelio Matamoros; Tara Sagebiel; Prajnan Das; Jane E Rogers; Jeana L Garris; Mariela A Blum; Brian Badgwell; Jaffer A Ajani
Journal:  Oncology       Date:  2015-07-08       Impact factor: 2.935

Review 4.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009.

Authors:  Therese A Dolecek; Jennifer M Propp; Nancy E Stroup; Carol Kruchko
Journal:  Neuro Oncol       Date:  2012-11       Impact factor: 12.300

5.  DO PROXIMAL AND DISTAL GASTRIC TUMOURS BEHAVE DIFFERENTLY?

Authors:  Laurence Bedin da Costa; Marcelo Garcia Toneto; Luis Fernando Moreira
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec

6.  Association of sporadic and familial Barrett's esophagus with breast cancer.

Authors:  M Q Chan; A E Blum; A K Chandar; A M L Kieber Emmons; Y Shindo; W Brock; G W Falk; M I Canto; J S Wang; P G Iyer; N J Shaheen; W M Grady; J A Abrams; P N Thota; K K Guda; A Chak
Journal:  Dis Esophagus       Date:  2018-04-01       Impact factor: 3.429

7.  Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates.

Authors:  Brenda K Edwards; Elizabeth Ward; Betsy A Kohler; Christie Eheman; Ann G Zauber; Robert N Anderson; Ahmedin Jemal; Maria J Schymura; Iris Lansdorp-Vogelaar; Laura C Seeff; Marjolein van Ballegooijen; S Luuk Goede; Lynn A G Ries
Journal:  Cancer       Date:  2010-02-01       Impact factor: 6.860

8.  Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.

Authors:  Ann S Hamilton; Steven T Fleming; Dian Wang; Michael Goodman; Xiao-Cheng Wu; Jean B Owen; Mary Lo; Alex Ho; Roger T Anderson; Trevor Thompson
Journal:  Am J Clin Oncol       Date:  2016-02       Impact factor: 2.339

9.  Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.

Authors:  Jeffrey J Tomaszewski; Erin L Richman; Natalia Sadetsky; Denise S O'Keefe; Peter R Carroll; Benjamin J Davies; June M Chan
Journal:  J Urol       Date:  2013-10-03       Impact factor: 7.450

Review 10.  Adjuvant therapy in gastric cancer: what is the optimal approach?

Authors:  Takashi Taketa; Kazuki Sudo; Roopma Wadhawa; Mariela M Blum; Jaffer A Ajani
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.